Eli Lilly News

The FDA has cleared a new Alzheimer's blood test developed by Roche and Eli Lilly, which is described as minimally invasive and aims to help identify symptoms e

Eli Lilly is filing lawsuits against six outlets that are selling unauthorized versions of its experimental weight-loss drug, retatrutide, which has not yet bee

Novo Nordisk is seeking a court injunction to block Eli Lilly's weight-loss drug advertisements, alleging that Lilly's ads mislead consumers with outdated studi

Scribe Therapeutics, a company specializing in gene therapies for heart diseases, saw its stock climb 67% after successfully raising $128.7 million in an upsize

Eli Lilly & Co.'s next-generation weight-loss shot did not increase overall heart risk in a new study, addressing concerns as it approaches regulatory review.

Two weight-loss drugmakers, Novo Nordisk and Eli Lilly, are engaged in a legal battle over the effectiveness of their respective medications.

Ozempic बनाने वाली कंपनी नोवो नॉर्डिस्क ने एली लिली पर "भ्रामक" विज्ञापन बनाने का आरोप लगाते हुए कानूनी कार्रवाई शुरू की है, जिसे एली लिली ने खारिज कर दिया है.

Novo Nordisk has sued rival Eli Lilly in a U.S. federal court, alleging false advertising regarding the efficacy of Lilly's weight-loss medicines compared to No

Novo Nordisk has filed a lawsuit against Eli Lilly, accusing its GLP-1 rival of using outdated data in its advertising campaigns.

Novo Nordisk is suing Eli Lilly, alleging that its rival used "false and materially misleading" advertisements for its weight-loss and anti-diabetes treatments.

Novo Nordisk is suing Eli Lilly, alleging false advertising by using outdated clinical trial data to misrepresent the effectiveness of its drugs.

Novo Nordisk is suing Eli Lilly in U.S. federal court for alleged false advertising regarding its weight-loss drugs, seeking to block Lilly's ads and implement

Novo Nordisk has filed a lawsuit against Eli Lilly, alleging that its rival used outdated data in advertisements to falsely claim its weight-loss products were